Altered major histocompatibility complex (MHC) determinant and m

Details Altered major histocompatibility complex (MHC) determinant and m Altered major histocompatibility complex (MHC) determinant and m

1995-01-09

2000-11-28

Wax, Robert A.

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

4352523, 4353201, 530350, 530386, 530391, 530394, 530395, 536234, C07K 1900, C12N 1562, C12N 1585, A61K 39385

Patent

active

061534080

ABSTRACT:
An altered MHC class I determinant comprises .alpha..sub.1, .alpha..sub.2, .alpha..sub.3, .beta..sub.2 -microglobulin (.beta..sub.2 m) polypeptide domains encoded by a mammalian MHC class I locus in which the .alpha..sub.3 domain is covalently linked to the .beta..sub.2 M domain. An altered MHC class II determinant comprises .alpha..sub.1, .alpha..sub.2, .beta..sub.1, and .beta..sub.2 polypeptide domains encoded by a mammalian MHC class II locus, in which the domains are covalently linked to form a polypeptide comprising the .beta..sub.2 -.alpha..sub.2 -.alpha..sub.1 -.beta..sub.1 domains in sequence. The altered MHC class I and class II determinants can be associated with an antigen to elicit an immune response. The invention can be used in the immunization or treatment of diseases such as AIDS, multiple sclerosis, lupus erythematosus, toxic shock or snake bite.

REFERENCES:
patent: 4478823 (1984-10-01), Sanderson
patent: 4946778 (1990-08-01), Ladner
patent: 5242687 (1993-09-01), Tykocinski et al.
patent: 5260422 (1993-11-01), Clark et al.
patent: 5528498 (1996-06-01), Huston et al.
patent: 5583031 (1996-12-01), Stern
Lone, Y.-C., et al., International Immunology, vol. 6, No. 10, "Role of the CDR1 region of the TCR B-chain in the binding to purified MHC-peptide complex", pp. 1561-1565, 1994.
Abastado, J.-P., et al., Journal of Experimental Medicine, vol. 182, No. 8, "Dimerization of Soluble Major Histocompatibility Complex-Peptide Complexes Is Sufficient for Activation of T Cell Hybridoma and Induction of Unresponsiveness", pp. 439-447, 1995.
Gill, R. F., et al., Journal of Immunological Methods, vol. 176, "Systematic Identification of H-2 Kd binding peptides and induction of peptide specific CTL", pp. 245-253, 1994.
Quesnel, A., et al., Peptide Research, vol. 8, No. 1, "Use of Synthetic Peptide Libraries for the H-2Kd Binding Motif Identification", pp. 44-51, 1995.
Germain, R. N., in Fundamental Immunology, 3rd Edition, Paul, W. E., Ed., Raven Press, New York, "Antigen Processing and Presentation", pp. 646-650, 1993.
Smiley, S.T., et al., Proceedings of the National Academy of Sciences, U.S.A., vol. 93, "Truncation of the class II beta-chain cytoplasmic domain influences the level of class II/invariant chain-derived peptide complexes", pp. 241-244, 1996.
Ocjius, P. M. et al., 1993, Biochemical and Biophysical Research Communications, 197(3): 1216-1222.
Mottez, E., et al., 1991, European Journal of Immunology, 21: 467-471.
Maryanski, J. L., et al., 1989, European Journal of Immunology, 19: 193-196.
Novotny, J., et al., 1989, Research in Immunology, 140: 145-158.
Abastado, J.-P. et al., 1989, Research in Immunology, 140: 581-594.
Godeau, F., et al., 1992, The Journal of Biological Chemistry, 267(34): 24223-24229.
Jaulin, C., et al., 1992, Journal of Immunology 149(12): 3990-3994.
Ojcius, P. M., et al., 1993, European Journal of Immunology 23: 1118-1124.
Choppin, J., et al., 1990, Journal of Experimental Medicine, 172: 889-899.
Mottez et al., "A single-chain murine class I major transplantation antigen", Eur. J. Immunol. 21: 467-471 (1991).
Rock et al., "Reassociation with beta2-microglobulin is necessary for Db class I major histocompatibility complex binding of an exogenous influenza peptide", Proc. Natl. Acad. Sci. USA 88: 301-304 (1991).
Rock et al., "Dissociation of beta2-microglobulin leads to the accumulation of a substantial pool of inactive class I MHC heavy chains on the cell surface", Cell 65: 611-620 (1991).
Elliot et al., "Peptide-induced conformational change of the class I heavy chain", Nature 351: 402-406 (1991).
Huston et al., "Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli", Proc. Natl. Acad. Sci. USA 85: 5879-5883 (1988).
Novotny et al., "A soluble, single-chain T-cell receptor fragment endowed with antigen-combining properties", Proc. Natl. Acad. Sci. USA 88: 8646-8650 (1991).
Roitt et al., ed. "Immunology", Gower Medical Publishing, 1985 p. 4.7.

Affiliated with

Also associated with

Rating

Altered major histocompatibility complex (MHC) determinant and m does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Altered major histocompatibility complex (MHC) determinant and m, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Altered major histocompatibility complex (MHC) determinant and m will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1723889